Myanmar - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Myanmar Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases grew 1% year on year. In 2019, the country was number 19 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 3,679 Cases. Myanmar is overtaken by Pakistan, which was number 18 at 3,820 Cases and is followed by Vietnam with 3,517 Cases. India lead the ranking with 66,255 Cases in 2019, +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 3,679.00 |
| 2018 | 3,497.00 |
| 2017 | 3,281.00 |
| 2016 | 3,213.00 |
| 2015 | 2,793.00 |
How does Myanmar rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 17 |
#17
Pakistan
|
3,925 | 2019 | +5.6 % | +3.9 % | View data | |
| 19 |
#19
Myanmar
|
3,679 | 2019 | +5.2 % | +1.0 % | View data | |
| 20 |
#20
Vietnam
|
3,517 | 2019 | +6.2 % | +9.9 % | View data | |